Business● Low27m ago · Nov 10, 2026, 12:33 PM
Arbutus Biopharma GAAP EPS of $0.30 beats by $0.32, revenue of $0.3M misses by $0.7M
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Arbutus Biopharma reported GAAP earnings per share that beat estimates, but its revenue fell short of expectations. This indicates mixed financial results for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business24m agoSea shares fall as earnings miss despite Q3 revenue beatSeeking Alpha TechBusiness24m agoMasterCraft Boat beats top-line and bottom-line estimates; updates FY26 outlookSeeking Alpha TechBusiness26m agoMicron, Nvidia, Lam Research removed from BofA's US 1 listSeeking Alpha TechBusiness28m agoHive Digital Q2 earnings, HPC revenue miss as revenue holds broadly stableSeeking Alpha Tech